XML 33 R4.htm IDEA: XBRL DOCUMENT v2.4.0.8
INTERIM CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (USD $)
In Thousands, except Share data, unless otherwise specified
 3 Months Ended
Sep. 30, 2014
Sep. 30, 2013
CONSOLIDATED STATEMENTS OF OPERATIONS [Abstract]    
Revenues $ 95 $ 95
Cost of revenues (3) (3)
Gross profit 92 92
Research and development expenses (5,736) (5,497)
Less participation by the Office of the Chief Scientist and other parties 1,699 2,374
Research and development expenses, net (4,037) (3,123)
General and administrative expenses (1,678) (1,829)
Operating loss (5,623) (4,860)
Financial income (expense), net (288) 105
Net loss $ (5,911) $ (4,755)
Loss per share:    
Basic and diluted net loss per share $ (0.09) $ (0.08)
Weighted average number of shares used in computing basic and diluted net loss per share 69,131,435 59,254,132